<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1276">
  <stage>Registered</stage>
  <submitdate>12/05/2006</submitdate>
  <approvaldate>16/05/2006</approvaldate>
  <actrnumber>ACTRN12606000177550</actrnumber>
  <trial_identification>
    <studytitle>Preventing the development of panic disorder in vulnerable patients with chronic obstructive pulmonary disease</studytitle>
    <scientifictitle>Psychological and physiological correlates of panic disorder in patients with chronic obstructive pulmonary disease, and efficacy of prevention of panic anxiety using cognitive behaviour therapy</scientifictitle>
    <utrn />
    <trialacronym>Anxiety in COPD project</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic obstructive pulmonary disease (COPD)</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Chronic obstructive pulmonary disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>20 patients with COPD receive a one hour session of cognitive behaviour therapy per week for four weeks - this is the intervention.                                                                                              All continue to receive active treatment as usual for their COPD.  All subjects are then assessed every six months over an 18 month follow-up period.</interventions>
    <comparator>20 control patients with COPD don't receive this intervention.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The effectiveness of the brief, standardised CBT intervention in decreasing the likelihood that patients will develop symptoms of panic disorder</outcome>
      <timepoint>An assessment session every six months over 18 month follow-up period.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To reduce the personal and economic burder associated with the development of panic disorder in COPD patients.</outcome>
      <timepoint>An assessment session every six months over 18 month follow-up period.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of COPD, with no age limits on enrolment. </inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Lack of written fluency in EnglishA co-existing severe disease and/or mental illness.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1 / Phase 2</phase>
    <anticipatedstartdate>7/04/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Nicole Livermore (enrolled in part-time PhD degree at University of Sydney</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>The Prince of Wales Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>The University of Sydney</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr. Louise Sharpe, School of Psychology, University of Sydney, (N. Livermore's primary supervisor)</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>40 patients with COPD are randomly allocated to either receive a four session preventative CBT intervention, or not receive this intervention in addition to usual treatment.  Subjects are then followed up every six months for 18 months to investigate the efficacy of the intervention in preventing the development/worsening of panic anxiety symptoms.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Prince of Wales Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>29/05/2002</ethicapprovaldate>
      <hrec>02/120</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Sydney</ethicname>
      <ethicaddress />
      <ethicapprovaldate>10/09/2002</ethicapprovaldate>
      <hrec>2998 </hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Louise Sharpe</name>
      <address>School of Psychology
University of Sydney
F - 12 Transient Building
Camperdown NSW 2006</address>
      <phone>+61 2 93514558</phone>
      <fax>+61 2 93517328</fax>
      <email>louises@psych.usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Louise Sharpe</name>
      <address>School of Psychology
University of Sydney
F - 12 Transient Building
Camperdown NSW 2006</address>
      <phone>+61 2 93514558</phone>
      <fax>+61 2 93517328</fax>
      <email>louises@psych.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>